Effects of Serelaxin in Patients with Acute Heart Failure
Novartis Pharmaceuticals
Marco Metra; John R Teerlink; Gad Cotter; Beth A Davison; G Michael Felker; Gerasimos Filippatos; Barry H Greenberg; Peter S Pang; Piotr Ponikowski; Adriaan A Voors; Kirkwood F Adams; Stefan D Anker; Alexandra Arias-Mendoza; Patricio Avendaño; Fernando Bacal; Michael Böhm; Guillermo Bortman; John G F Cleland; Alain Cohen-Solal; Maria G Crespo-Leiro; Maria Dorobantu; Luis E Echeverría; Roberto Ferrari; Sorel Goland; Eva Goncalvesová; Assen Goudev; Lars Køber; Juan Lema-Osores; Phillip D Levy; Kenneth McDonald; Pravin Manga; Béla Merkely; Christian Mueller; Burkert Pieske; Jose Silva-Cardoso; Jindřich Špinar; Iain Squire; Janina Stępińska; Walter Van Mieghem; Dirk von Lewinski; Gerhard Wikström; Mehmet B Yilmaz; Nicole Hagner; Thomas Holbro; Tsushung A Hua; Shalini V Sabarwal; Thomas Severin; Peter Szecsödy; Claudio Gimpelewicz